Exchange: NASDAQ·Updated 03:59 PM EST

About DECA

About

Semnur Pharmaceuticals, Inc. engages in developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. It offers the product, SP-102, a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain. The company was founded in 2013 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

Advertisement|Remove ads.